[1]郑婷婷李锦卞婧张威甄健存.以合理用药绩效管理促进医院高质量发展[J].中国卫生质量管理,2022,29(12):47-50.[doi:10.13912/j.cnki.chqm.2022.29.12.11 ]
　ZHENG Tingting,LI Jin,BIAN Jing.To Promote the High Quality Development of Hospitals by Performance Management of Rational Drug Use[J].Chinese Health Quality Management,2022,29(12):47-50.[doi:10.13912/j.cnki.chqm.2022.29.12.11 ]

点击复制

以合理用药绩效管理促进医院高质量发展

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R] 卷: 第29卷期数: 2022年12期页码: 47-50 栏目: 绩效管理与医院高质量发展出版日期: 2022-12-28

Title:: To Promote the High Quality Development of Hospitals by Performance Management of Rational Drug Use

作者:: 郑婷婷李锦卞婧张威甄健存; 北京积水潭医院

Author(s):: ZHENG Tingting; LI Jin; BIAN Jing; Beijing Jishuitan Hospital

关键词:: 合理用药; 绩效指标; 绩效管理

Keywords:: Rational Drug Use; Performance Indicators; Performance Management

分类号:: R197.323；R9

DOI:: 10.13912/j.cnki.chqm.2022.29.12.11

文献标志码:: B

摘要:: 合理用药是保障医疗质量与安全的重要举措之一。通过设置合理用药绩效考核指标，管控重点药品涉及的科室及医生，审核处方、医嘱优化药物治疗方案，动态监测与超常预警异常用药，限制重点监控药品用量以及实时公示药品使用情况等一系列管控方法，2017年-2021年次均药品费用均保持在较低水平，处方合格率总体上升；2021年门急诊次均药品费用和住院次均药品费用均较2020年下降，处方合格率达99.05%，合理用药绩效指标整体完成情况良好，达到了预期目标。还需继续加大抗菌药物合理使用管理力度，强化临床药师实时审核医嘱，优化抗感染治疗方案等。

Abstract:: Rational drug use is one of the important measures to ensure medical quality and safety. By a series of control method of setting the rational drug use performance appraisal index, controlling key drugs involved departments and doctors, reviewing the prescription and the doctor's advice to optimize drug therapy, dynamic monitoring and supernormal warning of abnormal medication, limiting dosage of monitored drugs and real-time publicizing the drug usage, the average drug cost per time was kept at a low level and the qualified rate of prescriptions increased overall from 2017 to 2021. In 2021, the average outpatient and emergency drug costs and hospitalization drug costs decreased compared with those in 2020. The qualified rate of prescriptions reached 99.05%, and the overall performance indicators of rational drug use were well completed, reaching the expected goal. It was also necessary to continue to strengthen the management of rational use of antibiotics, strengthen the real-time review of medical orders by clinical pharmacists, and optimize the anti-infection treatment plan.

参考文献/References:

［1］国家卫生健康委体制改革司. 关于全面推开公立医院综合改革工作的通知［EB/OL］. (2017-04-24)［2022-06-17］.http://www.gov.cn/xinwen/2017-05/01/content_5189918.htm#1. ［2］国务院办公厅. 关于加强三级公立医院绩效考核工作的意见［EB/OL］. (2019-01-30)［2022-06-17］.http://www.gov.cn/zhengce/content/2019-01/30/content_5362266.htm. ［3］国家卫生健康委医政医管局. 关于印发加强医疗机构药事管理促进合理用药的意见的通知［EB/OL］. (2020-02-26) ［2022-06-17］. http://www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac094c47a1fc 39cf00f3960e.shtml. ［4］杨光. 公立医院药品零差价后的影响及措施［J］. 中国药物经济学, 2017, 12(10): 27-29. ［5］刘梅, 罗燕梅, 董志强. 实行药品零差价对临床药品应用的影响［J］. 中国医院药学杂志, 2018, 38(24): 2603-2606. ［6］甄健存, 李锦, 郑婷婷,等. 运用药品预算管理降低药品成本［J］.中国医院, 2018, 22(6): 66-67. ［7］毛璐, 李锦, 甄健存. 优化动态监测项目及超常预警对于医院合理用药的效果分析［J］.中国医院药学杂志, 2017, 37(23): 2396-2399. ［8］国家卫生健康委医政医管局. 国家卫生健康委办公厅关于2019年度全国三级公立医院绩效考核国家监测分析有关情况的通报［EB/OL］.(2021-03-30)［2022-06-17］. http://www.nhc.gov.cn/yzygj/s3594q/202103/559684cae3e6485fb309976b081ac3 f0.shtml. ［9］中华医学会骨科学分会关节外科学组.中国人工关节感染诊断与治疗指南［J］.中华外科杂志, 2021, 59(6): 430-442. ［10］毛璐, 张伯松, 姜璐,等.载万古霉素骨水泥的人体局部释放及全身药物浓度监测［J］.中国医院药学杂志, 2019, 39(3): 244-246. ［11］JIAO WP. Diagnosis-related groups' payment reform in Beijing［J］.Chin Med J (Engl), 2018, 131(14): 1763-1764. ［12］YUAN SW, LIU WW, WEI FQ, et al. Impacts of hospital payment based on Diagnosis Related Groups (DRGs) with global budget on resource use and quality of care: a case study in China［J］.Iran J Public Health, 2019, 48(2): 238-246. ［13］杨香瑜, 陈辰, 张韶辉,等. 临床药师基于疾病诊断相关分组数据参与消化内科药事精细化管理的实践［J］.中南药学, 2020, 18(7): 1219-1222. ［14］郭振军，左燕，廉江平，等.以重点监控药品管理促进合理用药水平提升［J］.中国卫生质量管理，2022,29（9）：68-71.

相似文献/References:

[1]王凯顾嘉钦朱珺侯旭敏.精细化管理促进辅助药物合理使用[J].中国卫生质量管理,2019,26(03):54.[doi:10.13912/j.cnki.chqm.2019.26.3.16]
[2]赵娴张青鹿秀丽王雨来.基于HIMSS EMRAM 7 标准的合理用药系统建立与应用[J].中国卫生质量管理,2019,26(03):90.[doi:10.13912/j.cnki.chqm.2019.26.3.25]
[3]王栋罗平刘韶尹桃龚志成.住院患者静脉输液专项管理实践[J].中国卫生质量管理,2022,29(05):34.[doi:10.13912/j.cnki.chqm.2022.29.5.09 ]
　WANG Dong,LUO Ping,LIU Shao.Special Management Practice of Intravenous Infusion for Inpatients[J].Chinese Health Quality Management,2022,29(12):34.[doi:10.13912/j.cnki.chqm.2022.29.5.09 ]
[4]邓明林伟龙时黎明杨谨成安宇杨娟周成诚杨文静.北京市79家医院抗肿瘤药物规范使用现状与影响因素分析[J].中国卫生质量管理,2022,29(11):21.[doi:10.13912/j.cnki.chqm.2022.29.11.06 ]
　DENG Ming,LIN Weilong,SHI Liming.Current Status and Influencing Factors of Standardized Use of Antitumor Drugs in 79 Hospitals in Beijing[J].Chinese Health Quality Management,2022,29(12):21.[doi:10.13912/j.cnki.chqm.2022.29.11.06 ]
[5]府裕琦吕娟丽陈熙吕红梅杨小强赵颖波.基于全国抗菌药物临床应用监测网的手术组病例用药合理性分析[J].中国卫生质量管理,2024,31(04):1.[doi:10.13912/j.cnki.chqm.2024.31.4.01]
　FU Yuqi,LV Juanli,CHEN Xi,et al.Analysis of the Rationality of Drug Use in the Surgical Group Based on the Center for Antibacterial Surveillance[J].Chinese Health Quality Management,2024,31(12):1.[doi:10.13912/j.cnki.chqm.2024.31.4.01]
[6]陈熙府裕琦吕红梅赵颖波.我国医疗机构患者自备输注药品管理现状调查分析[J].中国卫生质量管理,2024,31(04):11.[doi:10.13912/j.cnki.chqm.2024.31.4.03]
　CHEN Xi,FU Yuqi,LV Hongmei,et al.Investigation and Analysis of Management Status about Patient Self-Provided Infusion Drugs in Medical Institutions in China[J].Chinese Health Quality Management,2024,31(12):11.[doi:10.13912/j.cnki.chqm.2024.31.4.03]
[7]陈嘉泳李炳坤.广东省援外医疗队绩效分析及建议[J].中国卫生质量管理,2025,32(02):88.[doi:10.13912/j.cnki.chqm.2025.32.2.20]
　CHEN Jiayong,LI Bingkun.Performance Analysis and Suggestions of Guangdong Foreign Aid Medical Team[J].Chinese Health Quality Management,2025,32(12):88.[doi:10.13912/j.cnki.chqm.2025.32.2.20]

更新日期/Last Update: 2022-12-28